Marksans Pharma Ltd board approves preferential issue of warrants

The Board of Directors of Marksans Pharma Ltd at its meeting held today, i.e., 15th June, 2021, has considered and approved, subject to approval of the Shareholders of the Company, the following issue of convertible warrants on preferential basis.

- 10,00,000 convertible warrants to Mr. Mark Saldanha (Promoter of the Company) at a price of INR 74.00 per warrant, being the price not less than the price determined in accordance with Chapter V of SEBI (ICDR) Regulations, 2018; and

- 4,93,24,324 convertible warrants to OrbiMed Asia IV Mauritius FVCI Limited at a price of INR 74.00 per warrant, being the price not less than the price determined in accordance with Chapter V ofSEBI (lCDR) Regulations, 2018.

Shares of MARKSANS PHARMA LTD. was last trading in BSE at Rs.94.5 as compared to the previous close of Rs. 83.7. The total number of shares traded during the day was 6881012 in over 34768 trades.

The stock hit an intraday high of Rs. 97.5 and intraday low of 84.65. The net turnover during the day was Rs. 633616224.

Source : Equity Bulls

Keywords